StockNews.com cut shares of USANA Health Sciences (NYSE:USNA - Free Report) from a strong-buy rating to a buy rating in a research report sent to investors on Friday morning.
Separately, DA Davidson upped their price target on shares of USANA Health Sciences from $35.00 to $38.00 and gave the company a "neutral" rating in a research report on Thursday, January 2nd.
View Our Latest Report on USNA
USANA Health Sciences Stock Down 0.8 %
USNA traded down $0.24 during trading on Friday, hitting $31.45. 141,706 shares of the stock were exchanged, compared to its average volume of 129,139. USANA Health Sciences has a 1-year low of $30.13 and a 1-year high of $50.32. The stock has a fifty day moving average price of $34.29 and a two-hundred day moving average price of $36.97. The firm has a market capitalization of $599.44 million, a P/E ratio of 11.11, a PEG ratio of 0.84 and a beta of 0.87.
Hedge Funds Weigh In On USANA Health Sciences
Hedge funds and other institutional investors have recently made changes to their positions in the stock. R Squared Ltd purchased a new stake in USANA Health Sciences during the 4th quarter valued at approximately $28,000. Safe Harbor Fiduciary LLC purchased a new stake in shares of USANA Health Sciences during the third quarter worth approximately $30,000. KBC Group NV raised its stake in shares of USANA Health Sciences by 96.6% during the third quarter. KBC Group NV now owns 1,056 shares of the company's stock worth $40,000 after purchasing an additional 519 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new stake in shares of USANA Health Sciences during the fourth quarter worth $83,000. Finally, Quantbot Technologies LP purchased a new position in USANA Health Sciences in the 4th quarter valued at $132,000. Hedge funds and other institutional investors own 54.25% of the company's stock.
About USANA Health Sciences
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Featured Stories
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for March 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
